Sarepta Therapeutics (SRPT) is a publicly traded Healthcare sector company. As of October 14, 2026, SRPT trades at $16.75 with a market cap of $1.84B and a P/E ratio of -13.19. SRPT moved +1.42% today. Year to date, SRPT is -22.52%; over the trailing twelve months it is -24.82%. Its 52-week range spans $10.42 to $110.00. Analyst consensus is neutral with an average price target of $21.64. Rallies surfaces SRPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sarepta Therapeutics (SRPT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SRPT moved +1.42% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $16.75 |
| Market Cap | $1.84B |
| P/E Ratio | -13.19 |
| EPS | $-1.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $110.00 |
| 52-Week Low | $10.42 |
| Volume | 40 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.97B |
| Net Income | $-136.72M |
| Gross Margin | 0.00% |
16 analysts cover SRPT: 0 strong buy, 3 buy, 9 hold, 4 sell, 0 strong sell. Consensus rating is neutral. Average price target: $21.64.